ArticleBMC complementary medicine and therapies2026

The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD.

Greg Roebuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.